In the CH₃CO radical, a team from ISMO and PhLAM has revealed a previously unobserved coupling between the spin of an unpaired electron and the internal rotation of a methyl group (CH₃).
Read MoreHighlights
Highlights
Proof of concept for the combination of Gemcitabine-loaded MOF and hadrontherapy to treat hypoxic cancers
In a study published in the International Journal of Pharmaceutics, ISMO researchers have published the first study of an innovative strategy that combines porous organometallic nanoparticles (nanoMOFs) loaded with the anti-cancer drug Gemcitabine monophosphate (GemMP) and helium and carbon ion hadrontherapy.
Read More